RaiseTrack

This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: investor relationships, two agreeing sources.

GT Biopharma Form D (2026)

GT Biopharma reported $7,750,000 raised in an SEC Form D filed on 2026-09-29.

Company
GT Biopharma
Round type
Form D
Date
2026-09-29
Amount
$7.75M
Industry
Biotechnology
Location
California

Summary

The SEC Form D for GT Biopharma, filed on 2026-09-29, reports $7,750,000 raised. It was listed in the Raise Track Update of 2026-09-30. Filing: https://www.sec.gov/Archives/edgar/data/109657/000010965726000001/0000109657-26-000001-index.htm

This page is not indexed by search engines yet because the filing is its only source.

Investors

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/109657/000010965726000001/0000109657-26-000001-index.htm
    Type: sec filing. Accessed 2026-10-12.
    SEC Form D filed 2026-09-29 by GT Biopharma, Inc. Reports $7,750,000 of securities sold. It does not name investors or a round type.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-09-30/
    Type: other verified public source. Accessed 2026-10-12.
    Raise Track Update for 2026-09-30, Section 3 (SEC Form D filings). Lists GT Biopharma, state CALIFORNIA, industry Biotechnology, amount raised $7,750,000.